The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dave, S. J.
Right arrow Articles by Sodetz, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dave, S. J.
Right arrow Articles by Sodetz, J. M.

The Journal of Immunology, Vol 144, Issue 8 3087-3090, Copyright © 1990 by American Association of Immunologists

ARTICLES

Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors

SJ Dave and JM Sodetz
Department of Chemistry, University of South Carolina, Columbia 29208.

Inability of the membrane attack complex of C (C5b-9) to efficiently lyse E from the same species has been attributed to one or more membrane-associated proteins that are collectively called homologous restriction factors. These include a 65,000 Mr protein referred to as the C8 binding protein or homologous restriction factor and a 20,000 Mr protein referred to as P-18, HRF20, CD59 Ag, or MIRL. Both are found on nucleated cells as well as E and both protect against complement- mediated lysis by interfering with C8 and/or C9 function within C5b-9. The exact mechanism by which these factors restrict activity is unknown but studies with purified C8 binding protein suggest they may interact specifically with the gamma subunit of C8. To determine directly if gamma is the target of restriction factors, a derivative of human C8 lacking this subunit was evaluated for its potential to lyse homologous cells. This derivative (C8') was previously shown to be functionally equivalent to normal C8 in a heterologous sheep E system. Here, it is compared to normal C8 by using human E as target cells. Results indicate no difference between the ability of C8 and C8' to incorporate into HuEAC1-7, to mediate subsequent C9 binding and to promote hemolysis. Thus, the presence or absence of gamma has no effect on homologous restriction of C5b-9, therefore gamma cannot be the primary target of homologous restriction factors.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. F. Schreck, M. E. Plumb, P. L. Platteborze, K. M. Kaufman, G. A. Michelotti, C. S. Letson, and J. M. Sodetz
Expression and Characterization of Recombinant Subunits of Human Complement Component C8: Further Analysis of the Function of C8{alpha} and C8{gamma}
J. Immunol., July 1, 1998; 161(1): 311 - 318.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. H. Lockert, K. M. Kaufman, C.-P. Chang, T. Hüsler, J. M. Sodetz, and P. J. Sims
Identity of the Segment of Human Complement C8 Recognized by Complement Regulatory Protein CD59
J. Biol. Chem., August 25, 1995; 270(34): 19723 - 19728.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.